DK0745122T3 - Galninreceptor, nukleinsyrer, transformerede celler og anvendelser heraf - Google Patents

Galninreceptor, nukleinsyrer, transformerede celler og anvendelser heraf

Info

Publication number
DK0745122T3
DK0745122T3 DK95909825T DK95909825T DK0745122T3 DK 0745122 T3 DK0745122 T3 DK 0745122T3 DK 95909825 T DK95909825 T DK 95909825T DK 95909825 T DK95909825 T DK 95909825T DK 0745122 T3 DK0745122 T3 DK 0745122T3
Authority
DK
Denmark
Prior art keywords
receptor
galnin
nucleic acids
transformed cells
polypeptides
Prior art date
Application number
DK95909825T
Other languages
English (en)
Inventor
Brigitte Amiranoff
Estelle Habert-Ortoli
Isabelle Loquet
Original Assignee
Aventis Pharma Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa, Inst Nat Sante Rech Med filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0745122T3 publication Critical patent/DK0745122T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95909825T 1994-02-17 1995-02-14 Galninreceptor, nukleinsyrer, transformerede celler og anvendelser heraf DK0745122T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9401808A FR2716205B1 (fr) 1994-02-17 1994-02-17 Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
PCT/FR1995/000172 WO1995022608A1 (fr) 1994-02-17 1995-02-14 Recepteur galanine, acides nucleiques, cellules transformees et utilisations

Publications (1)

Publication Number Publication Date
DK0745122T3 true DK0745122T3 (da) 2009-03-30

Family

ID=9460177

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95909825T DK0745122T3 (da) 1994-02-17 1995-02-14 Galninreceptor, nukleinsyrer, transformerede celler og anvendelser heraf

Country Status (12)

Country Link
US (2) US6447996B1 (da)
EP (1) EP0745122B1 (da)
JP (1) JP3989536B2 (da)
AT (1) ATE414771T1 (da)
AU (1) AU1814995A (da)
CA (1) CA2182621C (da)
DE (1) DE69535886D1 (da)
DK (1) DK0745122T3 (da)
ES (1) ES2317643T3 (da)
FR (1) FR2716205B1 (da)
PT (1) PT745122E (da)
WO (1) WO1995022608A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711830A3 (en) * 1994-10-13 1997-06-11 Takeda Chemical Industries Ltd Murine and human galanin receptor
AU730137B2 (en) * 1996-01-24 2001-03-01 H. Lundbeck A/S DNA encoding galanin GALR2 receptors and uses thereof
US5972624A (en) * 1996-01-24 1999-10-26 Synaptic Pharmaceutical Corporation Method of identifying ligands which bind recombinant galanin receptor (GALR2)
US6410686B1 (en) 1996-06-05 2002-06-25 Bayer Corporation Galanin receptor 2 protein
SE9602822D0 (sv) 1996-07-19 1996-07-19 Astra Pharma Inc New receptor
US6329197B2 (en) 1996-10-09 2001-12-11 Synaptic Pharmaceutical Corporation DNA encoding galanin GALR3 receptors and uses thereof
US6693182B1 (en) 1997-08-22 2004-02-17 Schering Corporation Mammalian galanin receptors
EP1268546A2 (en) * 2000-04-06 2003-01-02 PHARMACIA & UPJOHN COMPANY G protein-coupled receptors
JP2005507654A (ja) * 2001-08-27 2005-03-24 トゥラリック インコーポレイテッド 増幅した癌遺伝子およびそれらの癌への関与
JP2008517930A (ja) * 2004-10-21 2008-05-29 トランス テック ファーマ，インコーポレイテッド ＧａｌＲ１のアゴニストとしてのビススルホンアミド化合物、組成物、及び使用法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015015A1 (en) * 1991-02-25 1992-09-03 Zymogenetic, Inc. Methods for detecting galanin antagonists
SE9101472D0 (sv) * 1991-05-15 1991-05-15 Trion Forskning & Utveckling Galanin antagonist
CA2138999C (en) * 1992-06-23 2010-02-23 Stuart C. Sealfon Cloning and expression of gonadotropin-releasing hormone receptor

Also Published As

Publication number Publication date
ATE414771T1 (de) 2008-12-15
FR2716205A1 (fr) 1995-08-18
CA2182621A1 (fr) 1995-08-24
JP3989536B2 (ja) 2007-10-10
WO1995022608A1 (fr) 1995-08-24
JPH09510344A (ja) 1997-10-21
ES2317643T3 (es) 2009-04-16
US6447996B1 (en) 2002-09-10
AU1814995A (en) 1995-09-04
EP0745122B1 (fr) 2008-11-19
FR2716205B1 (fr) 1996-04-12
DE69535886D1 (de) 2009-01-02
PT745122E (pt) 2009-02-10
EP0745122A1 (fr) 1996-12-04
CA2182621C (fr) 2011-06-14
US20030166895A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
DE69435108D1 (de) Defekte adenovirus-vektoren und deren verwendung in der gentherapie
FI973055A0 (fi) Soluja yhdistelmä-DNA-adenovirusten tuottamiseksi
ATE353906T1 (de) Cd27 ligand
HUP9800901A3 (en) Process, medium and cell culture system for the preparation of recombinant factor viii in a protein free medium
EP0670730A4 (en) FUSION PROTEINS COMPRISING A TUMOR NECROSIS FACTOR RECEPTOR.
BRPI9715219C8 (pt) vetor recombinante de expressão, e célula hospedeira procariótica.
DE69519547D1 (de) Reformer und diesen verwendendes Brennstoffzellensystem
DE69737978D1 (de) Als 2f1 bezeichnetes rezeptorprotein
NO910982D0 (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
IL132496A0 (en) Mammalian cytokine-like factor 7
BR9607583B1 (pt) plasmìdios procarióticos recombinantes.
FI962268L (fi) Homologinen, rekombinanttinen vasta-aineilmentämisjärjestelmä rottien tai hiirien soluille
IT1291135B1 (it) Vettori ricombinanti utilizzabili in terapia genica
AU1814995A (en) Galanin receptor, nucleic acids, transformed cells and uses thereof
IL90334A0 (en) Genetic transformation of b.thuringiensis,vectors used therefor,host cells transformed by the vectors and use of said cells as insecticides
DE69514317D1 (de) Brennstoffzellenanode und Brennstoffzelle
DE69033756D1 (de) Gene, die für MACIF Proteine kodieren, Expressionsvektoren mit diesem Genen, und Transformantenzellen mit diesem Proteinen
NO892817D0 (no) Elektrodeelement for elektrokjemiske celler.
DE68908138D1 (de) Polypeptide mit zellausdehnungs-aktivitaet.
DE68907941D1 (de) Polypeptide mit zellausdehnungs-aktivitaet.
ATE294861T1 (de) Polypeptide mit opioider rezeptor-aktvität, für sie kodierende nukleinsäuren und ihre verwendungen
FI840104A7 (fi) Yhdistelmä-DNA-ekspressoimisvektoreita, jotka ovat käyttökelpoisia Bacillus- ja muissa isäntäsoluissa.
GB2284599A8 (en) Solid-electrolyte fuel cell electrode material andelectrode using same
CA2139430A1 (fr) Polypeptides ayant une activite de recepteur serotoninergique (5ht5a), acides nucleiques codant pour ces polypeptides et utilisations
TR26073A (tr) Bacillus thuringiensis jenleri,toksinleri ve insektisid olarak kullanimlari.